LYC Healthcare Berhad Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

LYC Healthcare Berhad hat in der Vergangenheit keine Dividende gezahlt.

Wichtige Informationen

n/a

Dividendenausschüttung

-16.9%

Rückkaufsrendite

Gesamte Aktionärsrendite	-16.9%
Zukünftige Dividendenrendite	n/a
Wachstum der Dividende	n/a
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	n/a
Ausschüttungsquote	n/a

Jüngste Updates zu Dividenden und Rückkäufen

Keine Aktualisierungen

Recent updates

Is LYC Healthcare Berhad (KLSE:LYC) Weighed On By Its Debt Load?

Nov 12

Shareholders May Be More Conservative With LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation For Now

Sep 20

LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 14

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Jul 04

Is LYC Healthcare Berhad (KLSE:LYC) A Risky Investment?

Mar 26

LYC Healthcare Berhad's (KLSE:LYC) Returns On Capital Are Heading Higher

Feb 01

It's Unlikely That The CEO Of LYC Healthcare Berhad (KLSE:LYC) Will See A Huge Pay Rise This Year

Sep 15

Here's Why LYC Healthcare Berhad (KLSE:LYC) Is Weighed Down By Its Debt Load

Sep 10

Investors Will Want LYC Healthcare Berhad's (KLSE:LYC) Growth In ROCE To Persist

May 11

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

Nov 29

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Jun 13

How Should Investors React To LYC Healthcare Berhad's (KLSE:LYC) CEO Pay?

Mar 01

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von LYC in der Vergangenheit stabil war.

Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von LYC gestiegen sind.

Dividendenrendite im Vergleich zum Markt

LYC Healthcare Berhad Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von LYC im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (LYC)	n/a
Untere 25 % des Marktes (MY)	1.9%
Markt Top 25 % (MY)	4.9%
Branchendurchschnitt (IT)	7.2%
Analystenprognose (LYC) (bis zu 3 Jahre)	n/a

Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von LYC im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von LYC im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von LYC, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da LYC keine Ausschüttungen gemeldet hat.

LYC Healthcare Berhad Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Updates zu Dividenden und Rückkäufen

Recent updates

Second quarter 2025 earnings released: RM0.004 loss per share (vs RM0.007 loss in 2Q 2024)

Is LYC Healthcare Berhad (KLSE:LYC) Weighed On By Its Debt Load?

LYC Healthcare Berhad Appoints Kong Sin Seng as Independent and Non Executive Chairman of Audit Committee

Wong Chew Weng agreed to acquire an additional 55% stake in Elite Dental Team Sdn Bhd from LYC Healthcare Berhad (KLSE:LYC) for MYR 6.5 million.

LYC Healthcare Berhad Approves Audit Committee Be Changed to Audit and Risk Management Committee, Effective September 28, 2024

Shareholders May Be More Conservative With LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation For Now

Take Care Before Diving Into The Deep End On LYC Healthcare Berhad (KLSE:LYC)

Full year 2024 earnings released: RM0.029 loss per share (vs RM0.035 loss in FY 2023)

LYC Healthcare Berhad, Annual General Meeting, Sep 27, 2024

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2024 earnings released: RM0.03 loss per share (vs RM0.035 loss in FY 2023)

New minor risk - Share price stability

LYC Healthcare Berhad (KLSE:LYC) Doing What It Can To Lift Shares

Lyc Healthcare Berhad Appoints Chong Sook Peng as Chief Financial Officer

Third quarter 2024 earnings released: RM0.006 loss per share (vs RM0.007 loss in 3Q 2023)

LYC Healthcare Berhad Announces Resignation of Mr. Cheah SEK Hon as Chief Financial Officer , Effective from 28 April 2024

LYC Healthcare Berhad Announces Resignation of Encik Ahmad Rafique Bin Mat Tahir as Chief Operating Officer, Effective 19 February.2024

Second quarter 2024 earnings released: RM0.006 loss per share (vs RM0.009 loss in 2Q 2023)

LYC Healthcare Berhad has filed a Follow-on Equity Offering in the amount of MYR 12.804571 million.

New minor risk - Share price stability

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

LYC Healthcare Berhad's (KLSE:LYC) CEO Compensation Is Looking A Bit Stretched At The Moment

Full year 2023 earnings released: RM0.035 loss per share (vs RM0.021 loss in FY 2022)

LYC Healthcare Berhad, Annual General Meeting, Sep 21, 2023

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2023 earnings released: RM0.035 loss per share (vs RM0.021 loss in FY 2022)

LYC Healthcare Berhad Appoints Poh Zuan Yin as Independent and Non Executive Member of Audit Committee

LYC Healthcare Berhad (KLSE:LYC) acquired 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei.

Is LYC Healthcare Berhad (KLSE:LYC) A Risky Investment?

Third quarter 2023 earnings released: RM0.007 loss per share (vs RM0.007 loss in 3Q 2022)

LYC Healthcare Berhad's (KLSE:LYC) Returns On Capital Are Heading Higher

Second quarter 2023 earnings released: RM0.009 loss per share (vs RM0.007 loss in 2Q 2022)

It's Unlikely That The CEO Of LYC Healthcare Berhad (KLSE:LYC) Will See A Huge Pay Rise This Year

Here's Why LYC Healthcare Berhad (KLSE:LYC) Is Weighed Down By Its Debt Load

LYC Healthcare Berhad announced a financing transaction

Full year 2022 earnings released: RM0.021 loss per share (vs RM0.033 loss in FY 2021)

LYC Healthcare Berhad, Annual General Meeting, Sep 22, 2022

LYC Healthcare Berhad (KLSE:LYC) entered into a conditional share sale agreement to acquire a 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei for MYR 5.5 million.

LYC Healthcare Berhad (KLSE:LYC) entered into a conditional share sale agreement to acquire a 55% stake in Elite Dental Team Sdn Bhd from Kenneth Wong Pak Ken, Wong Chew Weng, Carmen Yuen Chia-Wen, Yee Xin Le and Sylvia Lim Sze Wei for MYR 5.5 million.

LYC Healthcare Berhad Announces Appointment of Mr. Cheah SEK Hon as Chief Financial Officer

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investors Will Want LYC Healthcare Berhad's (KLSE:LYC) Growth In ROCE To Persist

LYC Healthcare Berhad (KLSE:LYC) agreed to acquire Tao Global Ventures Sdn Bhd from Dinesh A/L Kanasen and Sarahanna A/P Selvarajah for RMB 4 million.

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Does LYC Healthcare Berhad (KLSE:LYC) Have A Healthy Balance Sheet?

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2021 earnings released: RM0.033 loss per share (vs RM0.029 loss in FY 2020)

Is LYC Healthcare Berhad (KLSE:LYC) Using Too Much Debt?

Full year 2021 earnings released: RM0.032 loss per share (vs RM0.029 loss in FY 2020)

How Should Investors React To LYC Healthcare Berhad's (KLSE:LYC) CEO Pay?

Third quarter 2021 earnings released: RM0.013 loss per share (vs RM0.006 loss in 3Q 2020)

Non-Independent Non-Executive Director has left the company

LYC Healthcare Berhad Announces Resignation of Josephie Sui Sze Pin as Non Independent and Non Executive Member of Remuneration Committee

New 90-day low: RM0.25

New 90-day low: RM0.29

New 90-day low: RM0.30

New 90-day low: RM0.32

Second quarter 2021 earnings released: RM0.008 loss per share

LYC Healthcare Berhad (KLSE:LYC) acquired remaining 49% stake in LYC Cosmetic & Aesthetic Sdn Bhd from Xing Dao International Pte. Ltd for MYR 0.05 million.

New 90-day low: RM0.33

First quarter earnings released

First quarter earnings released

Stabilität und Wachstum des Zahlungsverkehrs

Dividendenrendite im Vergleich zum Markt

Gewinnausschüttung an die Aktionäre

Barausschüttung an die Aktionäre

Entdecken Sie dividendenstarke Unternehmen